46 related articles for article (PubMed ID: 17410527)
1. In situ evaluation of the impact of metformin or verapamil coadministration with vildagliptin on its regional absorption from the rabbit's intestine.
Elmeniar AM; Osman MA; El-Gizawy SA; Modi D; Charbe NB; El-Kattan AF; El-Tanani M; Haggag YA; Tambuwala MM
Biopharm Drug Dispos; 2024 Apr; 45(2):71-82. PubMed ID: 38400763
[TBL] [Abstract][Full Text] [Related]
2. Balanced Permeability Index: A Multiparameter Index for Improved In Vitro Permeability.
Weiss DR; Baylon JL; Evans ED; Paiva A; Everlof G; Cutrone J; Broccatelli F
ACS Med Chem Lett; 2024 Apr; 15(4):457-462. PubMed ID: 38628792
[TBL] [Abstract][Full Text] [Related]
3. Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Brain Levels of Drug in Rat.
Sánchez-Dengra B; Gonzalez-Alvarez I; Bermejo M; Gonzalez-Alvarez M
Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575476
[TBL] [Abstract][Full Text] [Related]
4. Square root law model for the delivery and intestinal absorption of drugs: a case of hydrophilic captopril.
Anuta V; Mircioiu C; Voicu V; Mircioiu I; Sandulovici R
Drug Deliv; 2021 Dec; 28(1):1685-1694. PubMed ID: 34355621
[TBL] [Abstract][Full Text] [Related]
5. Closed-Loop Doluisio (Colon, Small Intestine) and Single-Pass Intestinal Perfusion (Colon, Jejunum) in Rat-Biophysical Model and Predictions Based on Caco-2.
Lozoya-Agullo I; Gonzalez-Alvarez I; Zur M; Fine-Shamir N; Cohen Y; Markovic M; Garrigues TM; Dahan A; Gonzalez-Alvarez M; Merino-Sanjuán M; Bermejo M; Avdeef A
Pharm Res; 2017 Dec; 35(1):2. PubMed ID: 29288412
[TBL] [Abstract][Full Text] [Related]
6. Intestinal Permeability of β-Lapachone and Its Cyclodextrin Complexes and Physical Mixtures.
Mangas-Sanjuan V; Gutiérrez-Nieto J; Echezarreta-López M; González-Álvarez I; González-Álvarez M; Casabó VG; Bermejo M; Landin M
Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):795-806. PubMed ID: 26602766
[TBL] [Abstract][Full Text] [Related]
7. Role of the equilibrative and concentrative nucleoside transporters in the intestinal absorption of the nucleoside drug, ribavirin, in wild-type and Ent1(-/-) mice.
Moss AM; Endres CJ; Ruiz-Garcia A; Choi DS; Unadkat JD
Mol Pharm; 2012 Sep; 9(9):2442-9. PubMed ID: 22812541
[TBL] [Abstract][Full Text] [Related]
8. Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats.
Al-Salami H; Butt G; Tucker I; Golocorbin-Kon S; Mikov M
Eur J Drug Metab Pharmacokinet; 2012 Jun; 37(2):99-108. PubMed ID: 21874525
[TBL] [Abstract][Full Text] [Related]
9. In vitro-in situ permeability and dissolution of fexofenadine with kinetic modeling in the presence of sodium dodecyl sulfate.
Gundogdu E; Mangas-Sanjuan V; Gonzalez-Alvarez I; Bermejo M; Karasulu E
Eur J Drug Metab Pharmacokinet; 2012 Mar; 37(1):65-75. PubMed ID: 21833762
[TBL] [Abstract][Full Text] [Related]
10. Simulations of the nonlinear dose dependence for substrates of influx and efflux transporters in the human intestine.
Bolger MB; Lukacova V; Woltosz WS
AAPS J; 2009 Jun; 11(2):353-63. PubMed ID: 19434502
[TBL] [Abstract][Full Text] [Related]
11. The H2 receptor antagonist nizatidine is a P-glycoprotein substrate: characterization of its intestinal epithelial cell efflux transport.
Dahan A; Sabit H; Amidon GL
AAPS J; 2009 Jun; 11(2):205-13. PubMed ID: 19319690
[TBL] [Abstract][Full Text] [Related]
12. Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of p-glycoprotein.
Dahan A; Amidon GL
Pharm Res; 2009 Apr; 26(4):883-92. PubMed ID: 19048359
[TBL] [Abstract][Full Text] [Related]
13. Progress in the development of early diagnosis and a drug with unique pharmacology to improve cancer therapy.
Lehotzky A; Tokési N; Gonzalez-Alvarez I; Merino V; Bermejo M; Orosz F; Lau P; Kovacs GG; Ovádi J
Philos Trans A Math Phys Eng Sci; 2008 Oct; 366(1880):3599-617. PubMed ID: 18644768
[TBL] [Abstract][Full Text] [Related]
14. In situ kinetic modelling of intestinal efflux in rats: functional characterization of segmental differences and correlation with in vitro results.
González-Alvarez I; Fernández-Teruel C; Casabó-Alós VG; Garrigues TM; Polli JE; Ruiz-García A; Bermejo M
Biopharm Drug Dispos; 2007 Jul; 28(5):229-39. PubMed ID: 17410527
[TBL] [Abstract][Full Text] [Related]
15. Mathematical modelling of in situ and in vitro efflux of ciprofloxacin and grepafloxacin.
Rodríguez-Ibáñez M; Sánchez-Castaño G; Montalar-Montero M; Garrigues TM; Bermejo M; Merino V
Int J Pharm; 2006 Jan; 307(1):33-41. PubMed ID: 16257153
[TBL] [Abstract][Full Text] [Related]
16. Scaling of in vitro membrane permeability to predict P-glycoprotein-mediated drug absorption in vivo.
Shirasaka Y; Masaoka Y; Kataoka M; Sakuma S; Yamashita S
Drug Metab Dispos; 2008 May; 36(5):916-22. PubMed ID: 18276834
[TBL] [Abstract][Full Text] [Related]
17. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
Dahan A; Amidon GL
Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
[TBL] [Abstract][Full Text] [Related]
18. Human intestinal permeability.
Lennernäs H
J Pharm Sci; 1998 Apr; 87(4):403-10. PubMed ID: 9548891
[TBL] [Abstract][Full Text] [Related]
19. In vitro-in vivo correlation in P-glycoprotein mediated transport in intestinal absorption.
del Amo EM; Heikkinen AT; Mönkkönen J
Eur J Pharm Sci; 2009 Feb; 36(2-3):200-11. PubMed ID: 19063964
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
